Musk may be a business prankster but he's not pranking the judge. He set his own target by month end - it is very good odds that it will close. Musk appears to want to avoid disclosure of something in interrogations. Now we are waiting for an actual "funding secured." There is still 10% of juice left in the spread - the risk is well worth it here (especially on...
This morning I received a Spike Alert for price volatility at the open on Activision Blizzard NASDAQ:ATVI . Perhaps people are excited about Wrath of the Lich King classic being released? :D This swing trade occurs within the context of the Merger Arbitrage trade which has been going on for many months since Microsoft announced an offer of $95/share to purchase...
Pfizer Short Term - We look to Sell at 50.48 (stop at 52.47) Our outlook is bearish. Broken out of the triangle formation to the downside. This is negative for sentiment and the downtrend has potential to return. Further downside is expected although we prefer to sell into rallies close to the 51.00 level. Our profit targets will be 45.49 and 42.00...
Now that the board unanimously approved the merger, and the broad market is staging a relief rally or even a bottom, as inflation being under control potentially sets the stage for the Fed to pivot and stop hiking (at least this is what the market might be pricing in), $TWTR offers a good reward to risk entry to go long and pull off a merger arb trade here. Upside...
www.engadget.com Microsoft just made one of the largest-ever bids for a game studio. The company has announced plans to acquire Activision Blizzard for $95 per share, valuing the all-cash deal at an enormous $68.7 billion. The deal would make the combined entity the "third-largest" game company by revenue, according to Microsoft, and would put titles like Call...
As a followup to my post earlier today I wanted to give some additional perspective on past Merger Arbitrages, both good and bad, using the Baxter NYSE:BAX buyout of Hill-Rom last year and the failed buyout of Rite-Aid NYSE:RAD by Walgreens NASDAQ:WBA in 2015.